Copyright
©The Author(s) 2025.
World J Hepatol. Mar 27, 2025; 17(3): 101724
Published online Mar 27, 2025. doi: 10.4254/wjh.v17.i3.101724
Published online Mar 27, 2025. doi: 10.4254/wjh.v17.i3.101724
Figure 1 Screening and network pharmacology analysis of Yinchenhao decoction blood components and obstructive jaundice targets.
A: Study workflow: Yinchenhao decoction administered after obstructive jaundice for 3 days, followed by sacrifice and tissue collection on day 10; B: Venn diagrams illustrating the Yinchenhao decoction (YCHD) blood components and potential targets for obstructive jaundice; C: Protein-protein interaction network with 65 nodes and 382 edges; D: The top 10 terms for biological process, molecular function, and cellular component in Gene Ontology functional annotations; E: Kyoto Encyclopedia of Genes and Genomes enrichment analysis of key targets in YCHD; F: Network diagram illustrating the relationship between YCHD components, targets, and pathways, with 175 nodes: 11 components (orange hexagons), 144 targets (pink hexagons), and 20 pathways (green circles), connected by 957 edges. YCHD: Yinchenhao decoction; GO: Gene Ontology; EGFR: Epidermal growth factor receptor.
- Citation: Liu JJ, Mei HW, Jing YY, Li ZL, Wu SG, Yuan HX, Zhang XB. Yinchenhao decoction alleviates obstructive jaundice liver injury by modulating epidermal growth factor receptor and constitutive androstane receptor signaling. World J Hepatol 2025; 17(3): 101724
- URL: https://www.wjgnet.com/1948-5182/full/v17/i3/101724.htm
- DOI: https://dx.doi.org/10.4254/wjh.v17.i3.101724